Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cellebrite DI Ltd.
Report date August 25, 2026 · Filed August 27, 2026
Section 16 reporting ended · disclosed 2026-08-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary shares, par value NIS 0.00001SEC Table I · non-derivative | Direct | 765,249 |
Reported balance
After 2026-08-25 transaction · row 1
1 source rowRow 1 · 2026-08-25 · Sale · Disposed 25,299 · Balance 765,249 F1: The shares reported as disposed herein were granted on February 10, 2026 , in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.205 to $11.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares reported as disposed herein were granted on February 10, 2026 , in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.205 to $11.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 27, 2026 22:02 UTC | Cellebrite DI Ltd. CLBT · Entity 4238 | SaleOrdinary shares, par value NIS 0.00001 | 25,299 | $11.29 | $285,711.73 |
DisclosureSEC source: 0001628280-26-059297 · wk-form4_1787868122.xml · nonDerivative · entry 1 Hogan Thomas E. · CIK 0002013619 · Advisor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 765,249 F1 · kind: The shares reported as disposed herein were granted on February 10, 2026 , in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.205 to $11.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 22:17 UTC | Cellebrite DI Ltd. CLBT · Entity 4238 | SaleOrdinary shares, par value NIS 0.00001 | 139,713 | $15.39 | $2,149,638.19 |
DisclosureSEC source: 0001628280-26-056875 · wk-form4_1786659424.xml · nonDerivative · entry 2 Hogan Thomas E. · CIK 0002013619 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 790,548 F2 · kind: Shares withheld from the vesting and distribution of performance share awards to satisfy the reporting person's tax obligations. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.06 to $15.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 22:17 UTC | Cellebrite DI Ltd. CLBT · Entity 4238 | GrantOrdinary shares, par value NIS 0.00001 | 339,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-056875 · wk-form4_1786659424.xml · nonDerivative · entry 1 Hogan Thomas E. · CIK 0002013619 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 930,261 F1 · kind: Represents ordinary shares of the Issuer delivered pursuant to the terms of performance share awards made to the reporting person on September 19, 2025. The performance-based vesting requirements applicable to such awards were satisfied on August 11, 2026, which represents the date on which the level of performance attained was certified. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 11:29 UTC | Cellebrite DI Ltd. CLBT · Entity 4238 | SaleOrdinary shares, par value NIS 0.00001 | 103,188 | $15.76 | $1,625,892.04 |
DisclosureSEC source: 0001628280-26-047426 · wk-form4_1783423780.xml · nonDerivative · entry 1 Hogan Thomas E. · CIK 0002013619 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 590,777 F1 · shares: The shares reported as disposed herein were granted on September 19, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.